Alan J. Kivitz MD, MACR research
Abdominal Cramping/Pain
Boehringer Ingelheim - Hyoscine Butylbromide - 2005
Allergy/Seasonal rhinitis
Novartis - VAK694 - 2009
anemia
Luitpold - Ferric Carboxymaltose - 2010
GlaskoSmithKline - Novel Prolyl Hydroxylase Inhibitor Daprodustat - 2020
Ankle Sprain pain
Noven - Ketoprofen Patch - 2000
Ankylosing spondylitis
Pharmacia - Celecoxib - 2001
Immunex - Etanercept - 2001
Abbott - Adalimumab - 2003
Centocor - Golimumab - 2005
Abbott - Humira - 2010
Novartis - AIN457 - 2010
Sanofi - SAR153191 - 2009
Abbott - Humira - 2010
UCB - Certollizumab Pegol - 2010
Roche - Tocilizumab - 2011
Roche - Tocilizumab - 2011
Novartis - Secukinumab - 2012
Abbott - Questionnaire (AS/Back Pain) - 2012
Novartis - Secukinumab - 2012
Celgene - Apremilast - 2011
Merck - Simponi - 2013
Merck - MK-0663 - 2014
Pfizer - Tofacitinib - 2014
Janssen - Golimumab - 2015
Novartis - Secukinumab - 2015
AbbVie - Adalimumab - 2015
Janssen - Ustekinumab - 2016
UCB - Certolizumab Pegol - 2017
Janssen - Ustekinumab - 2017
UCB - Bimekizumab - 2017
Lilly - Ixekizumab (LY2439821) - 2017
Lilly - Ixekizumab - 2017
Novartis - Secukinumab - 2018
Novartis - Secukinumab - 2019
Novartis - Secukinumab - 2020
UCB - Bimekizumab - 2021
Novartis - Secukinumab - 2021
AbbVie - Upadacitinib - 2021
UCB - Bimekizumab - 2021
Novartis - Secukinumab - 2021
Anxiety or panic disorder
Schwarz - Niravam - 2005
Arthritis (Inflammatory)
Targeted Genetics - TNFR-Fc Fusion Gene - 2006
asthma
Byk Gulden/Altana - Roflumilast - 2002
atherosclerosis
Pfizer - ETC-642 - 2005
Autoimmune diseases
Medimmune - MEDI7734 - 2017
Back pain
Ortho-McNeil - Ultram - 1998
Pfizer - CJ13,974 - 1999
Ortho-McNeil - Tramadol - 1999
Merck - Cox II - 1999
Biovail - Tramadol - 2000
Pharmacia - Celecoxib - 2002
Pharmacia - Celecoxib - 2003
Purdue - BTDS - 2004
Endo - Lidocaine Patch - 2004
Dov Pharmaceuticals - Bicifadine - 2004
Hisamitsu - Ketaprofen Patch - 2005
Pfizer - Celecoxib - 2006
crohn’s disease
Abbott - Adalimumab - 2003
Abbott - Adalimumab - 2006
Pfizer - CP-690,550 - 2007
chronic pain
Ortho-McNeil - Ultram - 1997
Ortho-McNeil - Tramadol - 1998
Parke-Davis - Pregabalin - 1998
Purdue - Tramadol-OL - 1998
Purdue - Tramadol - 1998
Parke-Davis - Pregabalin - 1999
Endo - Oxycodone - 1999
Endo - Numorphan - 2000
Purdue - Hydromorphone Hydrochloride ER - 2000
Biovail - Tramadol - 2000
Endo - Oxymorphone - 2001
Shire - Propiram Fumarate - 2001
Sanofi-Synthlebo - Hyalgan - 2002
Alza/Johnson & Johnson - D-Trans fentanyl - 2002
Endo - Oxymorphone - 2003
Purdue - Hydromorphone HCl ER and Duragesic - 2003
Harris Interactive - Avinza - 2004
Abbott - Vicodin - 2005
Purdue - Hydromorphone Hydrochloride ER - 2005
Hisamitsu - Ketaprofen Patch - 2005
Sagemed - Questionnaire - 2006
Johnson & Johnson - CG5503 PR - 2006
Cephalon - Fentanyl Buccal - 2006
Cephalon - Fentanyl Buccal - 2008
Wyeth - MOA-728 - 2008
King Alpharma Convert - Embeda - 2010
Egalet - Egalet-002 Ader Oxycodone - 2016
opioid induced constipation
Johnson & Johnson - Questionnaire - 2008
Johnson & Johnson - Tapentadol IR and Oxycodone IR - 2008
Theravaince - TD-1211 - 2011
dequervain’s disease
Iomed - Iontophoresis - 2000
autoinjectors/devices
Centocor - Autoinjector - 2007
Abbott - Autoinjector (Humira)
Janssen - Autoinjector - 2013
Bristol Myers Squibb - Autoinjector - 2014
Medac - Methotrexate Autoinjector - 2012
Bristol Myers Squibb - Abatacept Injector - 2014
Antares - Methotrexate Autoinjector - 2010
Antares - Methotrexate Autoinjector - 2012
Amgen - Enbrel Autoinjector - 2013
Amgen - Enbrel Autoinjector - 2013
Genentech Brevacta - Tocilizumab - 2015
Coherus - CHS-1420 - 2016
Baxalta - M923 - 2015
diabetic foot ulcer
Pfizer - Antibiotic - 1998
Diabetes
Bristol Myers Squibb - Metformin - 2000
Novartis - Nateglinide and Valsartan - 2002
diabetic neuropathy
Abbott - ABT594 - 2000
Sanwa - SNK-860 - 2001
Pfizer - Pregabalin - 2004
Astellas - FK1706 - 2006
Takeda - TAK-583 - 2007
Johnson & Johnson - CG5503 - 2007
Adolor - ADL5859 - 2007
Forest - RGH-896 - 2008
Sangamo - SB-509 - 2007
Sangamo - SB-509 - 2007
Aegera - AEG33773 - 2009
Johnson & Johnson - Tapentadol - 2010
Daiichi Sankyo - DS-5565 - 2012
Pfizer - Pregabalin - 2011
Pfizer - Pregabalin - 2012
AstraZeneca - AVD5213 - 2014
Aptinyx - NYX-2925 - 2021
epicondylitis
Iomed - Iontophoresis - 2000
Hisamitsu - Ketaprofen Patch - 2005
Fibromyalgia
Ortho-McNeil - Tramadol - 1999
Parke-Davis - Pregabalin - 1999
Parke-Davis/Pfizer - Pregabalin - 2001
Cypress Bioscience - Fibromyalgia Questionnaire - 2002
Pfizer - CP-424,391 - 2003
Pfizer - Pregabalin - 2004
Cypress Biosciencec - Milnacipran - 2004
Orphan - Xyrem - 2004
Forest - Milnacipran - 2004
Pfizer - Reboxetine - 2006
Wyeth - DVS SR - 2006
Allergan - AGN 203818 - 2006
Pfizer - Reboxetine - 2007
Pfizer - Reboxetine - 2007
Boehringer Ingelheim - Pramipexole - 2008
Wyeth - DVS SR - 2008
Lilly - Questionnaire - 2008
Pfizer - Questionnaire - 2008
Jazz - Xyrem - 2008
Jazz - Interview/Questionnaire - 2009
Pfizer - Pregabalin - 2009
Jazz - Xyrem - 2010
Bioenergy Ribocor - D-Ribose - 2012
OMC Research - Pregabalin - 2012
Theravance - TD-9855 - 2013
Lilly - Duloxetine - 2014
Daiichi - DS-5565 - 2016
Teva - Fremanezumab - 2021
Aptinyx - NYX-2925 - 2022
genotype/Data collection/healthy volunteers
Genomics - DNA - 2000
Corrona - Data Collection on OA, RA, OP, PSA - 2002
Seracare - Genetics Blood Collection (Psoriasis, Lupus, RA, MS) - 2004
Asterand - Genetic Blood Collection (Lupus) - 2006
gerd/gi symptoms/regurgitation/erosive esophagitis
Reliant - Nizatidine ER - 2001
AstraZeneca - Esomeprazole - 2002
AstraZeneca - Esomeprazole - 2002
Takeda - TAK-370- 2002
Tap - Lansoprazole vs. Esomeprazole - 2002
AstraZeneca - Nexium - 2003
AstraZeneca - Nexium - 2003
AstraZeneca - Esomeprazole - 2003
AstraZeneca - AZD0865 - 2004
AstraZeneca - AZD0865 - 2004
AstraZeneca - Nexium - 2004
AstraZeneca - Prilosec OTC - 2005
Altana - Pantoprazole - 2005
Tap - TAK-390MR - 2005
Tap - TAK-390MR - 2005
Tap - TAK-390MR - 2006
Tap - Ilaprazole - 2007
AstraZeneca - AZD3355 - 2008
Eisai - Rabeprazole - 2008
Eisai - Rabeprazole - 2008
Tap (Takeda) - TAK-390MR - 2008
GI Dysfunction (opioid-induced)
Adolor Corp. - Opioid Therapy - 2001
Adolor - Data Collection Study - 2009
gout
Merck - Etoricoxib & Indomethacin - 2000
Bio-Technology General - No Study Medication - 2001
Tap - TMX-67 - 2002
Tap - Febuxostat - 2003
Savient - Peg-Uricase - 2006
Regeneron - Rilonacept - 2006
Tap - Febuxostat - 2006
AR Scientific - Colchicine - 2007
Regeneron - IL-1 Trap - 2007
Pfizer - Celebrex - 2008
Novartis - Canakinumab - 2008
Enzymerx - Uricase PEG 20 - 2009
Regeneron - Rilonacept - 2009
Biocryst - BCX4208 - 2010
Enzymerx - Uricase-PEG 20 - 2009
Novartis - ACZ885 - 2010
Biocryst - BCX4208 - 2010
Regeneron - Rilonacept - 2010
Nuon - Tranilast - 2010
Biocryst - BCX4208 - 2010
Takeda - Febuxostat - 2011
Metabolix - MBX 102 - 2011
Ardea - Allopurinol - 2011
Novartis - ACZ885 - 2011
Regeneron - Colchicine - 2011
Ardea - Lesinurad - 2011
Ardea - Lesinurad - 2011
Ardea - Febuxostat - 2016
Selecta - SEL-037 - 2015
Takeda - Febuxostat - 2015
Takeda - Febuxostat - 2016
Takeda - Febuxostat - 2015
Selecta - SEL-212 - 2016
Selecta - SEL-212 - 2018
Dr. Saag - Krystexxa - 2019
Selecta - Krystexxa - 2020
Ampel - Pegloticase - 2020
LG Chem - LC350189 - 2020
Horizon - Krystexxa/pegloticase - 2020
Arthrosi - AR882 - 2022
Selecta - SEL-212 - 2022
giant cell arteritis
Centocor - Infliximab - 2004
healthy volunteers
Merck - Alendronate Sodium - 2001
Pfizer - Bextra - 2002
Pharmacia - Celecoxib - 2002
Pfizer - Gabapentin - 2004
Pfizer - Celebrex - 2004
Array - ARRY-371797 - 2006
PLX Pharma - Aspirin-PC - 2009
Regeneron - REGN 475 - 2009
Primus - Botanical Source - 2013
Primus - Botanical Source - 2013
AggreGuide - ADP Assay for Antiplatelet Drugs - 2018
Navidea - Tc 99m Tilmanocept - 2021
hot flashes
Berlex - HRT - 1998
hypercholesterolemia/hyperlipidemia/dyslipidemia
Pharmacia - SD-5613 - 2001
AstraZeneca - Rosuvastatin, Atorvastatin, Simvastatin - 2002
AstraZeneca - Crestor - 2004
Abbott - Fenofibric Acid - 2006
Abbott - Niacin ER & Zocor - 2006
Abbott - Niaspan - 2008
Abbott - ABT-335 - 2008
Abbott - ABT-143 - 2008
Abbott - ABT-335 - 2010
Amgen - AMG 145 - 2011
Pfizer - PF-04950615 - 2011
Pfizer - PF-04950615 - 2011
Pfizer - PF-04950615 - 2012
Amgen - AMG 145 - 2012
Amgen - AMG 145 - 2012
Sanofi - REGN727/SAR236553 - 2011
Amgen - AMG 145 - 2013
Amgen - AMG 145 - 2013
Amgen - AMG 145 - 2013
Regeneron - Praluent - 2018
Pfizer - PF-04950615 - 2013
Merck - MK-0616 - 2022
Hyperplasia
Berlex - HRT - 1998
hypertension
Bristol Myers Squibb - Omapatrilat or Enalapril - 2000
Pharmacia - Celecoxib vs. Rofecoxib - 2001
Alteon - ALT-711 - 2002
NicOx - HCT 3012 - 2006
Novartis - Hydrochlorothiazide - 2006
insomnia
Sepracor - Zopiclone - 2001
Sepracor - Zopiclone - 2001
Neurocrine Biosciences - NBI-34060 - 2002
Neurocrine Biosciences - NBI-34060 - 2002
GlaxoSmithKline - GW679769 - 2006
Sepracor - Eszopiclone - 2007
Merck - MK-0822 - 2010
female stress urinary incontinence
Lilly/Boehringer Ingelheim - Duloxetine HCl - 2003
irritable bowel syndrome
GlaxoSmithKline - Alosetron - 1999
Forest - Dexloxiglumide - 2002
GlaxoSmithKline - Alosetron - 2003
chronic kidney disease
Orthobiotech - Epoetin Alfa - 2006
Amgen - Darbepoetin - 2012
lupus
LaJolla - LJP-394 - 2000
Genelabs - Prestara - 2003
LaJolla - LJPJ394 - 2004
LaJolla - Abetimus Sodium - 2004
Genetech - Rituximab - 2005
Medimmune - MEDI-545 - 2006
Schering Plough - IL-10 - 2006
Human Genome Sciences - Belimumab - 2007
Amgen - AMG 811 - 2007
Genentech - Rhumab Ifnalpha - 2007
Wyeth - SIB-087 - 2010
Amgen - AMG 557 - 2010
Amgen - AMG 811 - 2008
Cephalon - CEP-33457 - 2011
Argos Novo Nordisk - NNC0152-0000-0001
Amgen - AMG 557 - 2011
Centocor - CNTO 136 - 2011
Lilly - LY2127399 - 2013
Human Genome Sciences - Belimumab - 2013
UCB - Epratuzumab - 2014
Lilly - LY2127399 - 2014
Janssen - No study drug - 2014
Human Genome Sciences - Belimumab/Vaccine - 2014
GlaxoSmithKline - Belimumab - 2014
Resolve - RSLV-132 - 2014
Invion - INV103/Alachaperonin 10 - 2013
Biogen - BIIB059 - 2016
Celgene - CC-220 - 2017
Human Genome Sciences - Belimumab - 2017
Xencor - XmAb 5871 - 2017
Mallinckrodt - MNK14304067 - 2019
AstraZeneca - Observational - 2019
Nektar - NKTR-358 - 2019
Human Genome Sciences - Benlysta - 2020
Amgen - AMG 592 - 2020
Idorsia - Cenerimod - 2021
Amgen - AMG592 - 2021
metabolic syndrome
Abbott - Tarka & Hyzaar - 2004
Multiple sclerosis
Biogen - Natalizumab - 2006
NSAID-Induced GI Complications/Gastric ulcers
Searle - NSAID - 1991
AstraZeneca - Nexium - 2001
AstraZeneca - Nexium - 2001
AstraZeneca - Nexium - 2001
Pozen - PN200 - 2006
Horizon - HZT-501 - 2006
Pozen - PN400 - 2007
Pozen - PN400 - 2007
Pozen - PN400 - 2007
Pozen - PN400 - 2007
Sucampo - PI-8811 - 2008
Horizon - HZT-501 - 2009
Logical - LT-NS001 - 2010
Pozen - PA32540 - 2011
neuropathic pain
Pfizer - Pregabalin - 2000
Pfizer - Pregabalin - 2000
GlaxoSmithKline - GW493838 - 2002
NeurogesX - NGX 4010 - 2004
Obesity/weight loss
Sanofi-Synthelabo - SR141716 - 2001
Merck - L-000899055 - 2004
Merck - L-000899055 - 2005
Merck - MK-0364 - 2006
Orexigen - Naltrexone/Bupropion SR - 2012
EISAI - BELVIQ - 2014
osteoarthritis
SmithKline Beecham - NSAID - 1991
Chiesi - NSAID - 1995
Searle - Cox II - 1996
Searle - NSAID - 1992
Searle - Cox II - 1996
Merck - Cox II - 1996
Searle - Arthrotec - 1997
Searle - Cox II - 1996
Merck - Cox II - 1996
Merck - Cox II - 1996
Hyal - Gel - 1997
Searle - Cox II - 1997
Searle - Cox II - 1998
Merck - Cox II - 1997
Boehringer Ingelheim - Meloxicam/Diclofenac - 1997
Parkee-Davis - Gabapentin - 1998
Parke-Davis - Gabapentin - 1998
Merck - Cox II - 1998
Merck - Cox II - 1998
Merck - Cox II - 1998
RW Johnson - RWJ57504 - 1998
Roche - Trocade - 1998
Parke-Davis - Pregabalin - 1998
Searle - Oxaprozin Potassium - 1998
Chiesi - Piroxicam - 1998
Searle - Cox II - 1998
MacroChem - Topical Ibuprofen Gel - 1998
Merck - Cox II - 1999
Merck - Cox II - 1998
Parke-Davis - Darbufelone - 1999
Parke-Davis - Darbufelone - 1999
Searle - Valdecoxib - 1999
Searle - Valdecoxib - 1999
Searle - Valdecoxib - 1999
Zeneca - ZD6416 - 1999
Abbott - ABT594 - 1999
Merck - Cox II - 1999
Roberts - Propiram/Tramadol - 1999
Merck - Cox II - 1999
Searle - Cox II - 1999
Parke-Davis - Gabapentin - 1999
Parke-Davis - Gabapentin - 1999
Purdue - Buprenorphine - 1999
Merck - Cox II - 1999
Roxanne - Oxycodone - 2000
Searle - Celecoxib vs. Rofecoxib - 2000
Noven - Ketoprofen Patch - 2000
United Therapeutics - Ketotop - 2000
Biovail - Tramadol - 2000
Merck - MK-0966 - 2000
Pharmacia/Pfizer - Celecoxib vs. Rofecoxib - 2001
Endo - Dextromethorphan - 2001
Pharmacia/Pfizer - Celecoxib vs. Rofecoxib - 2001
Pfizer - CP-544,439 - 2001
Merck - Rofecoxib - 2001
Dimethaid - Pennsaid - 2001
Forest Laboratories - ML3000 - 2001
Novartis - COX189 - 2001
Searle - Celecoxib - 2001
Pharmacia - Celecoxib - 2001
Pharmacia - Valdecoxib/Celecoxib - 2001
Novartis - COX189 - 2001
Forest - ML3000 - 2001
Pfizer - CI-1045 - 2001
Forest - ML3000 - 2002
Shire - Dirame - 2002
Novartis - COX189 - 2002
AstraZeneca - AR-P900758XX - 2002
Pharmacia - Valdecoxib - 2002
Pharmacia - Celecoxib - 2002
McNeil - Acetaminophen - 2002
Merck - Etoricoxib vs. Diclofenac - 2002
Merckle - ML3000 - 2002
Grunenthal - CG5503 or Oxycodone - 2002
McNeil - Acetaminophen and Naproxen - 2002
Merck - Etoricoxib vs. Celecoxib, Ibuprofen - 2002
Biovail - Tramadol HCl ER - 2002
Pharmacia - SD-6010 - 2003
Purdue - OxyContin - 2003
Merck - Etoricoxib - 2003
Purdue - BTDS - 2003
Alticor - Magna Bloc - 2002
Labopharm - Tramadol HCl - 2003
Tap - Celebrex-Naproxen - 2003
Sanofi - Zolpidem - 2003
Pfizer - CI-1027 - 2003
Novartis - Lumiracoxib - 2003
Pfizer - Celebrex - 2003
Purdue - Buprenorphine - 2003
McNeil - Acetaminophen ER - 2004
Pfizer - SD-6010 - 2004
Amgen - Anakinra - 2004
Pfizer - Celebrex & Naproxen - 2004
Johnson & Johnson - CG5503 - 2004
Endo - Lidocaine Patch - 2004
Wyeth - TDS-943 - 2004
Pfizer - CJ-023,423 - 2004
Labopharm - Tramadol - 2004
Genzyme - Synvisc - 2004
Novartis - Lumiracoxib - 2004
Sanofi - Hyalgan - 2004
Novartis - Diclofenac Gel - 2004
GlaxoSmithKline - GW406381 - 2005
McNeil - Ketoprofen in Transfersome - 2005
Endo - Lidocaine 5% - 2005
Pfizer - Celecoxib - 2005
Pfizer - CJ-023,423 - 2005
Purdue - BTDS and OxylR - 2005
Regeneron - IL-1 Trap - 2005
NicOx - HCT3012 - 2005
Abbott - Vicodin - 2005
Primus - Limbrel - 2006
Seikagaku - Synvisc or Gel-200 - 2006
Bionicare - Knee device - 2006
Astellas - FK555 - 2006
Flexx - Euflexxa - 2006
Wyeth - PLA-695 - 2006
Johnson & Johnson - CG5503 - 2006
Pfizer - CE-224,535 - 2006
Rinat - RN624 - 2006
Wyeth - AGG-523 - 2006
Alpharma - Kadian NT - 2006
Alpharma - Kadian NT - 2006
Amgen - AMG 403 - 2007
NicOx - Naproxcinod - 2007
Merck - Ibuprofen - 2007
Zars - ThermoProfen - 2007
Endo - Lidocaine - 2007
Johnson & Johnson - CG5503 - 2007
Wyeth - TDS-943 - 2007
Pfizer - SD-6010 - 2007
Combinatorx - CRx-102 - 2007
Neuromed - NMED-1077 - 2007
Nicox - Naproxcinod - 2008
Hisamitsu - HKT-500 - 2007
Nicox - Naproxcinod - 2008
Pozen - PN 400 - 2008
IDEA - Ketoprofen - 2008
Merck - Naproxen and Ultracet - 2008
Anika - Monovisc - 2008
Purdue - BTDS - 2008
Pfizer - Tanezumab - 2008
Pfizer - Tanezumab - 2008
Johnson & Johnson - Tapentadol IR & Oxycodone IR - 2008
Regeneron - REGN 475 - 2009
Pfizer - Celebrex - 2007
Johnson & Johnson - JNJ 42160443 - 2009
Pfizer - Tanezumab - 2009
Adolor - ADL5859 & ADL5747 - 2010
Pfizer - Tanezumab - 2010
Pfizer - Tanezumab - 2010
Pfizer - Tanezumab - 2010
Bayer - UC-11 - 2010
Lilly - Duloxetine - 2010
Stryker - BMP-7 - 2010
Lilly - Naprosyn - 2010
Novartis - Canakinumab - 2010
Abbott - ABT 652 - 2010
Johnson & Johnson - JNJ-42160443 - 2010
Iroko - Diclofenac Nanoformulation - 2011
Abbott - ABT 652 - 2011
Array - ARRY-371797 - 2011
Iroko - Diclofenac Nanoformulation - 2011
Iroko - Diclofenac - 2011
Novum - Diclofenac Sodium - 2011
Fidia - Hymovis - 2012
Flexion - FX006 to Kenalog - 2011
Purdue - V116517 - 2012
Nektar - NKTR-181 - 2012
Iroko - Meloxicam - 2013
Ampio - Ampion - 2013
Iroko - Meloxicam - 2013
Q-Med - Durolane - 2013
Xoma - Gevokizumab - 2013
Xoma - Gevokizumab - 2012
Afferent - AF 219 - 2013
Forest - GRT6005 - 2013
Flexion - FX006 - 2013
Ampio - Ampion - 2014
Charleston - CCX168 - 2014
Genzyme - Synvisc - 2014
Samumed - SM04690 - 2014
Flexion - FX006 - 2015
Techfields - X0002 - 2013
Seikagaku - Gel One - 2014
AbbVie - ABT-981 - 2015
GlaxoSmithKline - Paracetamol - 2015
Cara - CR845 - 2015
Regeneron - Fasinumab - 2015
Flexion - FX006 - 2015
AbbVie - ABT-981 - 2016
Cytori - Adipose Derived Regenerative Cells - 2016
Samumed - SM04690 - 2016
Centrexion - CNTX-4975 - 2016
Flexion - FX006 - 2016
Vertex - VX-150 - 2016
Cara Therapeutics - CR845 - 2017
GlaxoSmithKline - GSK3196165 - 2017
Pfizer - Tanezumab - 2017
Samumed - SMO4690 - 2017
3V Medical - 3vM1001 Cream - 2017
Flexion - FX006 - 2018
Seikagaku - SI-613 - 2018
Flexion - FX006 - 2018
Regeneron - Fasinumab - 2018
Unity - UBX0101 - 2019
Galapagos - S2201086/GLPG1972 - 2019
Regeneron - Fasinumab - 2019
Regeneron - Fasinumab - 2019
Primus - PC-010 - 2019
Flexion - FX006 - 2019
Ampio - Ampion - 2020
Flexion - FX006 - 2020
Unity - UBX0101 - 2020
Calibr - KA34 - 2020
Taiwan Liposome - TLC599 - 2020
Samumed - SM04690 - 2020
Samumed - Radiographic Screening Study - 2020
Samumed - SM04690 - 2020
Novartis - LNA043 - 2021
Samumed - SM04690-OA-10 - 2021
Acadia - ACP-044 - 2022
Techfields - X0002 - 2022
Osteoarthritis or rheumatoid Arthritis
Searle - Cox II - 1997
Searle - Cox II - 1997
Searle - Cox II - 1998
Searle - Cox II - 1999
Merck - Biomarkers of Inflammation, No Drug - 2001
Merck - Etoricoxib - 2002
Merck - L-001069957 - 2004
Pfizer - Celecoxib - 2006
osteoporosis/osteopenia
Procter & Gamble - Risedronate - 1994
Parke-Davis - HRT - 1998
Pfizer - Droloxifene - 1998
Aventis - Risedronate - 1999
NPS/Allelix - PTH - 2000
Merck - L-845704 - 2000
Merck - Alendronate - 2001
Wyeth Ayerst - TSE-424 - 2001
Proctor & Gamble and Aventis - Risedronate - 2001
Pfizer - Atorvastatin - 2001
Pharmacia - Celecoxib - 2001
Wyeth Ayerst - Bazedoxifene Acetate - 2001
Organon - Tibolone - 2002
Novartis - Zolendronic Acid - 2002
Lilly - Teriparatide and Raloxifene - 2002
Amgen - AMG 162 - 2002
Merck - Alendronate Risedronate - 2002
Merck - Alendronate - 2003
Roche - Ibandronate - 2004
Aventis - Teriparatide - 2004
Lilly - Arzoxifene - 2004
Amgen - AMG 162 - 2004
Amgen - AMG 162 - 2004
Lilly - Forteo - 2004
GlaxoSmithKline - Ibandronate - 2005
Merck - MK-217A - 2005
Amgen - Denosumab - 2006
Roche - Boniva vs. Actonel - 2006
Amgen - Denosumab - 2006
GlaxoSmithKline - Boniva - 2006
Deltanoid - DP001 - 2006
GlaxoSmithKline - SB-751689 - 2007
Primus - Fosteum - 2007
Amgen - AMG 785 - 2007
Amgen - AMG 785 - 2008
Roche - Ibandronate - 2008
Merck - MK-0822 - 2009
Unigene/Tarsa - Calcitonin Nasal Spray - 2008
Amgen - Denosumab - 2009
Merck - MK-5442 - 2010
Amgen - AMG 167 - 2010
Amgen - AMG 162 Denosumab - 2009
Amgen - Prolia - 2010
Merck - Odanacatib - 2010
Novartis - BPS804 - 2012
Amgen - Denosumab - 2014
Amgen - AMG 785 - 2013
Lilly - Teriparatide and Risedronate - 2014
Merck - MK-0822 - 2014
Amgen - Risedronate - 2015
Pfenex - PF708 - 2017
Dr. Saag - Bisphosphonates - 2016
Amgen - Romosozumab - 2018
National Bone Health Alliance: Dr. Silverman - Bisphosphonates - 2018
Amgen - Romosozumab - 2018
UC Davis - LLP2A-Alendronate - 2019
Oscotec - SKI-O-703 - 2020
Radius - Abaloparatide-SC - 2020
Sandoz - GP2411 (Biosimilar) - 2020
Teva - TVP-009P - 2021
overactive bladder
Yamanouchi - Vesicare - 2004
Targacept - Dexmecamylamine - 2013
Polymyalgia rheumatica
Regeneron - IL-1 Trap - 2005
polymyositis & dermatomyositis
Trubuon - TRU-015 - 2004
MedImmune - MEDI-545 - 2008
Horizon - Prednisone - 2016
Kezar - KZR-616 - 2021
AbbVie - ABBV-154 - 2022
post herpetic neuralgia
Pfizer - S,S-Reboxetine - 2004
Neurogesx - NGXZ-4010 - 2005
Pfizer - Reboxetine - 2006
King - T-62 - 2007
Pfizer - RN624 - 2007
Post-operative pain
Searle - Cox II - 1998
Searle - Cox II - 1998
Psoriasis
Alexion - H5F1.1-MAB - 2000
Abgenix - ABX-IL8 - 2000
Serono - Onercept - 2002
Genentech - Efalizumab - 2002
Amgen - Enbrel - 2004
Biogen - Amevive - 2003
Genentech - Raptiva - 2005
Amgen - Enbrel - 2006
Novartis - AIN457 - 2006
Schering Plough - SCH 900875 - 2007
Wyeth - ILV-094 - 2007
Novartis - AIN457 - 2008
Genentech - Raptiva - 2008
Schering Plough - SCH 9000222 - 2010
Novartis - Secukinumab - 2011
Novartis - Secukinumab - 2012
Amgen - Etanercept - 2013
Merck - SCH 9000222/MK-3222 - 2013
Novartis - Secukinumab - 2013
Novartis - Secukinumab - 2013
Novartis - Secukinumab - 2014
Novartis - Ustekinumab - 2014
Kadmon - PF-04965842 - 2015
Coherus - CHS0214 - 2014
Kadmon - KD025 - 2016
Janssen - CNTO 1959 - 2016
Boehringer Ingelheim - Risankizumab vs. Ustekinumab - 2015
Boehringer Ingelheim - BI 695501 - 2016
Lilly - LY3041658 - 2018
Celgene - CC-9006-CP-002 - 2018
Prothena - PRX003 - 2016
Arcutis - ARQ-151 - 2020
psoriatic arthritis
Immunex - Enbrel - 2000
Pharmacia - Celecoxib - 2001
Xoma - Efalizumab - 2003
Abbott - Humira - 2003
Centocor - Golimumab - 2005
Bristol Myers Squibb - Abatacept - 2007
Centocor - Ustekinumab - 2009
UCB Schwarz - Certolizumab Pegol - 2010
Roche - RO5310074 - 2010
Centocor - Ustekinumab - 2011
Amgen - AMG827 - 2012
Amgen - Enbrel - 2013
Celgene - Apremilast - 2012
Celgene - Apremilast - 2013
Bristol Myers Squibb - BMS-945429 - 2012
Novartis - Secukinumab - 2011
Novartis - Secukinumab - 2013
Lilly - LY2439821 - 2014
Celgene - Apremilast - 2014
Pfizer - Tofacitinib - 2014
Novartis - Secukinumab - 2014
Amgen - Brodalumab - 2015
Novartis - Secukinumab - 2015
Pfizer - Tofacitinib - 2015
Janssen - Golimumab - 2016
Lilly - LY2439821 - 2016
Novartis - Secukinumab - 2016
AbbVie - BI655066/ABBV-066/Risankizumab - 2016
Amgen - Etanercept - 2017
UCB - Bimekizumab - 2017
Novartis - Secukinumab - 2017
Novartis - Secukinumab - 2018
AbbVie - Upadacitinib - 2019
AbbVie - Adalimumab - 2019
AbbVie - Upadacitinib - 2019
Bristol Myers Squibb - BMS-986165 - 2020
AbbVie - Risankizumab - 2020
Gilead - Filgotinib - 2020
Gilead - Filgotinib - 2020
UCB - Bimekizumab - 2021
UCB - Bimekizumab - 2021
Novartis - Secukinumab - 2021
Celgene - CC-10004 - 2022
Nimbus - NDI034858 - 2022
benign prostatic hyperplasia
Sanofi - Registry and Survey - 2004
pulmonary arterial hypertension
Actelion - Questionnaire - 2003
Actelion - Questionnaire - 2005
raynaud’s
Otsuka - OPC-28326 - 2001
Otsuka - Pletal (Cilostazol)- 2002
Pfizer - Phosphodiesterase 5 Inhibitor (PF-00489791) - 2010
Covis - Nitroglycerine, Vascana - 2016
Primus - Diosmiplex (Vasculera) - 2016
renal insufficiency
Amgen - AMG162 - 2008
Astellas - Regadenoson - 2008
respiratory tract infections
Aventis - Ketek - 2001
restless legs syndrome
GlaxoSmithKline - Ropinirole - 2006
GlaxoSmithKline - GSK1838262 - 2012
rheumatoid arthritis
Greenwich - NSAID - 1992
Pfizer - Anti-Rheumatic - 1994
Pfizer - Anti-Rheumatic - 1996
Boston Life - NSAID - 1996
Pfizer - BMD Drug - 1996
Millenium - Genetic - 1996
Searle - Cox II - 1996
Searle - Cox II - 1996
Boston Life - NSAID - 1997
Schering Plough - Interleukin - 1997
Pfizer - CP195,543 - 1997
Boehringer Ingelheim - Meloxicam - 1997
Immunex - Anti-TNF - 1997
Searle - Cox II - 1997
Merck - Cox II - 1997
Schering Plough - Interleukin - 1998
Merck - Cox II - 1998
Schering Plough - Interleukin - 1998
Parke-Davis - NSAID - 1998
Parke-Davis - NSAID - 1998
Immune Response - Vaccine - 1998
AutoImmune - Colloral - 1998
RW Johnson - RW57504 - 1998
Lilly - IND55091 - 1998
Roche - Trocade - 1998
Immunex - TNF - 1999
Inflammatics - LeukoVAX - 1999
Schering Plough - Tenovil - 1999
Corixa/Anergen - AG4263 - 1999
Merck - Cox II - 1998
Amgen - PEGTNF - 1999
Fujisawa - Prograf - 1999
Merck - Cox II - 1999
Amgen - Anakinra - 1999
Centocor - Remicade - 1999
Amgen - Anakinra - 1999
Knoll - AntiTNF - 1999
Alexion - 5G1.1 - 1999
Roche - Trocade - 1999
Searle - Cox II - 1999
Searle - Valdecoxib - 1999
Searle - Cox II - 1999
Merck - Cox II - 1999
Immunex - Enbrel - 2000
Merck - Cox II - 2000
Searle - Valdecoxib - 2000
IDEC - Clenoliximab - 2000
Alexion - h5G1.1-mab - 2000
Centocor - Remicade - 2000
Novartis - COX189 - 2000
Knoll - Observational for RA - 2000
Abgenix - ABX-IL8 - 2000
Knoll - Anti-TNF - 2000
Novartis - Celecoxib - 2000
Vertex - VX-745 - 2000
Serono - IFN-beta-Ia - 2001
Serono - Onercept r-hTBP-1 - 2001
Bristol Myers Squibb - BMS-188667 - 2001
Novartis - COX189 - 2001
AstraZeneca - ZD2315 - 2001
Amgen - Kineret - 2001
Boehringer Ingelheim - Meloxicam - 2001
Bristol Myers Squibb - BMS-188667 - 2001
MedImmune - MEDI-522 - 2001
Immunex - IL-1RII - 2001
Regeneron - IL-1Trap - 2001
MedImmune - MEDI-522 - 2001
Immunex - Questionnaire - 2001
Angiotech - Paxeed - 2002
Immunex - Enbrel - 2002
Alexion - h5G1.1-mab - 2002
Amgen - AMG 719 - 2002
Amgen - PEG sTNF-RI - 2002
Immunex - IL-1RI - 2002
Xoma - Efalizumab - 2002
Regeneron - IL1 Trap - 2002
Scios - SCIO-469 - 2002
GenMab - HuMax-CD4 - 2002
Elan - Antegren (Natalizumab) - 2004
Boehringer Ingelheim - Meloxicam - 2002
ISIS - TNF-alpha Antisense Oligonucleotide - 2002
Pharmacia - Celecoxib - 2002
Amgen - Anakinra - 2002
Wyeth - CC1-779 - 2002
Immunex - Enbrel - 2002
Genentech - MabThera - 2003
Genmab - Humax IL15 - 2003
Bristol Myers Squibb - BMS-188667 - 2002
Abbott - D2E7 - 2002
Lilly - Biomarkers in RA (no drug) - 2002
Regeneron - IL-1 Trap - 2002
Bristol Myers Squibb - BMS-188667 - 2002
Pharmacia - CDP-870 - 2002
Phytomedics - Tripterygium Wilfordii Hook F - 2003
Novartis - COX 189 - 2003
Aventis - HMR3480 - 2003
IDEC - Rituximab - 2003
Pfizer - Bextra - 2003
NARAC - Blood Collection Study - 2002
Merck - Etoricoxib - 2003
Neurogen - NGD 2000-1 Dibesylate - 2003
Pharmacia - CDP-870 - 2003
GlaxoSmithKline - GW406381X - 2003
Bristol Myers Squibb - BMS-188667 - 2003
Fresnius Hemocare - Prosorba - 2003
Abbott - Adalimumab - 2003
Wyeth - CCI-779 - 2004
Wyeth - TMI-005 - 2004
Abbott - Humira - 2004
Amgen - Etanercept - 2004
NIH - DNAJ Peptide (dnaJp1) - 2004
Roche - Observational - 2004
Ortho Biotech - Procrit - 2004
University of Alabama at Birmingham - Etanercept - 2004
University of Massachusetts - Marine and Botanical Oils - 2004
Wyeth - TMI-005 - 2004
Genentech - rhuMAb 2H7 - 2004
Scios - SCIO-469 - 2004
Takeda - TAK-715 - 2004
Bristol Myers Squibb - BMS-188667 - 2004
Trubuon - TRU-015 - 2004
Amgen - Enbrel - 2004
Fresnius Hemocare - Prosorba - 2004
Pfizer - CP-690,550 - 2004
Regeneron - IL-1 Trap - 2004
Celltech - CDP-870 - 2005
Merrimack - MM-093 - 2005
Genmab - HuMax CD20 - 2005
GlaxoSmithKline - GW406381 - 2005
Incyte - INCB003284 - 2005
Amgen - Enbrel - 2005
Genentech - PRO97796 (BR3-Fc) - 2005
Roche - MRA - 2005
Roche - MRA - 2004
Roche - MRA - 2005
Wyeth - ERB-041 - 2005
CombinatorX - CRX-119N - 2005
Wyeth - ERB-041 - 2005
Targeted Genetics - TNFR-Fc Fusion Gene - 2005
Bristo Myers Squibb - Abatacept - 2005
Rigel - R935788 - 2005
Centocor - Golimumab - 2005
Centocor - Golimumab - 2005
Centocor - Golimumab - 2005
Roche - MRA - 2005
Genentech - Rituximab - 2005
Genentech - Rituximab - 2005
Genentech - Rituximab - 2005
Merck - Etoricoxib - 2005
Abbott - Humira - 2006
Amgen - AMG 108 - 2006
Regeneron - IL1 Trap - 2005
PDL BioPharma - Fontolizumab - 2006
Biogen-Idec - Rituxin - 2006
University of PA - Questionnaire for MTX - 2006
Centocor - Golimumab - 2006
Rigel - R935788 - 2006
Genentech - PRO97769 - 2006
Novartis - AIN457 - 2006
Alza/Johnson & Johnson - RJW-445380 - 2006
Proctor and Gamble - PG-760564 - 2006
Array - ARRY-438162 - 2006
Abbott - Humira - 2006
Genentech - Ocrelizumab - 2006
Genentech - Rituxin - 2006
Genentech - Ocrelizumab - 2006
Pfizer - Maraviroc - 2006
Merrimack - MM-093 - 2007
Pfizer - CE-224,535 - 2007
Pfizer - CP-690,550 - 2007
Pfizer - PD 0360324 - 2007
Biogen - BG9924 - 2007
Incyte - INCB018424 (Ruxolitinib) - 2007
Roche - Tocilizumab - 2007
Adolor - ADL5859 - 2007
Serono - Atacicept - 2007
Regeneron - REGN88 (IL6R-mAb) - 2007
Medarex - MDX-1342 - 2007
Combinatorx - CRX-102 - 2007
Bristol Myers Squibb - Abatacept - 2007
Bristol Myers Squibb - Abatacept - 2007
Abbott - Humira - 2007
Centocor - Golimumab - 2007
Incyte - INCB018424 (Ruxolitinib) - 2008
Pfizer - PH-797804 - 2008
Regeneron - REGN88 - 2008
Incyte - INCB028050 (Baricitinib) - 2008
Pfizer - 0360324 - 2008
Regeneron - REGN88 - 2008
Genentech - Rituximab - 2008
Centocor - Golimumab - 2008
Pfizer - CP-690,550 - 2008
Biogen - BIIB023 - 2008
Incyte - INCB28050 - 2009
Nuon - Tranilast - 2009
Roche - Tocilizumab - 2009
Genentech - MTRX1011A - 2008
Amgen - Observational Study - 2008
Centocor - CNTO 136 - 2008
Incyte - INCB 2805 - 2009
UCB/Swartz - Certolizumab Pegol - 2010
Lexicon - LX3305 - 2010
Pfizer - PF-04171327 - 2010
Pfizer - PF-04236921 - 2010
UCB - Certolizumab Pegol - 2010
Genentech - MLTA3698A - 2010
UCB - CDP6038 - 2010
Wyeth - ILV-094 - 2010
Bristol Myers Squibb - Abatacept - 2010
Amgen - AMG 827 - 2010
NIH - Switch to Anti-TNF - 2010
Regeneron - Actemra - 2010
Roche - Actemra - 2009
Roche - Actemra - 2010
Antares - MTX Autoinjector - 2010
Vertex - VX-509 - 2010
Pfizer - CP-690,550 - 2009
Biogen - Blood Draw - 2010
Sanofi - SAR153191 - 2010
Astellas - Orencia - 2011
Sanofi - SAR153191 - 2011
Lilly - LY3009104 - 2011
Celgene - Apremilast - 2011
UCB - Cimzia - 2011
Johnson & Johnson - NJ-38518168 - 2011
Johnson & Johnson - JNJ39758979 - 2011
Roche - Tocilizumab - 2011
Roche - Tocilizumab - 2011
Roche - Tocilizumab - 2011
UCB - Cimzia - 2011
UCB - Cimzia - 2010
Pfizer - CP-690,550 - 2011
Chelsea - CH-4051 - 2011
Celgene - PDA001 - 2011
Plexxikon - PLX3397 - 2011
Centocor - Golimumab - 2011
Zalicus - Z102 - 2011
Abbott - Humira - 2010
Astrazeneca - Fostamatinib Disodium - 2010
NIH - Lovastatin - 2008
Portola - PRT062607 - 2011
Astrazeneca - Fostamatinib Disodium - 2012
Astrazeneca - Fostamatinib Disodium - 2012
Bristol Myers Squibb - BMS817399 - 2012
Pfizer - CP-690,550 - 2012
Antares - MTX Injector - 2012
Antares - MTX Injector - 2012
Sanofi - SAR153191 - 2012
Genentech - Rituximab - 2012
Astellas - ASP2408 - 2012
Medac - MTX Injector - 2012
AstraZeneca - Fostamatinib Disodium - 2010
Pfizer - PF-05280586 - 2012
Roche - Actemra - 2011
Vertex - VX509 - 2012
AstraZeneca - Fostamatinib Disodium - 2010
UCB - Cimzia - 2011
Incyte - INCB039110 - 2012
Astellas - ASP2409 - 2012
UCB - Cimzia - 2011
Vertex - VX-509 - 2012
Astellas - ASP015K - 2013
Astellas - ASP015K - 2013
AstraZeneca - Fostamatinib Disodium - 2013
Amgen - Etanercept - 2013
Molecular Research (Camcargo) - MRC375 - 2013
Abbott - Humira - 2013
Roche - Tocilizumab - 2010
Protalex - PRTX-100 - 2014
AbbVie - ABT 122 - 2014
Pfizer - PF-04171327 - 2011
Boehringer Ingelheim - BI 695500 vs. Rituximab - 2014
Merck - MK-0663 - 2014
Morphotek - MORAB-022 - 2014
Amplimmune - AMP-110 - 2014
Bristol Myers Squibb - Abatacept Injector - 2014
Sanofi - Sarilumab - 2014
Janssen - Remicade - 2014
Sanofi - Sarilumab - 2014
Galapagos - GLPG0634 - 2014
Galapagos - GLPG0634 - 2014
Amgen - Etanercept - 2014
Horizon - Duexis - 2014
AbbVie - ABT-494 - 2013
Pfizer - Tofacitinib - 2013
Pfizer - Tofacitinib - 2014
Sanofi - Sarilumab - 2015
AbbVie - ABT-494 - 2015
Coherus - CHS 0214 - 2014
Amplimmune - RA-AMP-110 - 2013
Janssen - CNTO136 (Sirukamab) - 2014
Janssen - CNTO136 (Sirukamab) - 2014
Pharmacyclics - PCI-45466 - 2014
Pfizer - Tofacitinib - 2015
Pfizer - OF-06438179 - 2015
Genentech - Tocilizumab - 2015
Crescendo - Vectrada - 2015
AbbVie - ABT-122 - 2016
Celgene - CC-292 - 2016
Pfizer - PF-06410293 - 2016
Fujifilm - FKB327 - 2016
Amgen - Denosumab - 2016
Sandoz - GP13-302 - 2016
Acerta - ACP-196 - 2016
Amgen - AMG 357 - 2016
Novartis - CFZ533 - 2016
Gilead - GS-4059 - 2016
Astellas - ASP5094 - 2016
Lilly - LY337641 - 2017
Merck - M2951 - 2017
Bristol Myers Squibb - Abatacept - 2016
AbbVie - ABT-494 - 2017
Gilead - GS-9876 - 2017
GlaxoSmithKline - GSK3196165 - 2017
MedImmune - MED14920 - 2017
AbbVie - ABT-494 - 2017
GlaxoSmithKline - GSK3196165 - 2017
AbbVie - ABT-494 - 2017
Pfizer - Tofacitinib - 2017
Amgen - ABP-798 - 2017
Bristol Myers Squibb - Abatacept - 2018
Gilead - Filgotinib - 2018
Gilead - Filgotinib - 2018
Amgen - Etanercept - 2018
Janssen - Simponi Aria vs. Remicade - 2018
Nichi-Iko - NI-071 & Remicade - 2018
Roche - RO7123520 - 2018
Set Point - Device/Vagal Stimulator - 2018
R-Pharm - Olokizumab - 2019
AbbVie - ABT-494 - 2019
Amgen - AMG 570 - 2019
Crescendo - Vectra DA Outcomes Study - 2019
Lilly - Baricitinib - 2019
Crescendo - Vectra Blood Test - 2020
Amgen - AMG 592 - 2020
Sanofi - Sarilumab - 2020
Navidea - Tilmanocept Uptake Value on Tc99m/Tilmanocept Planar Imaging - 2020
Oscotec - SKI-O-703 - 2020
VielaBio - VIB4920 - 2020
Target - Treatments against RA & Effect on PET/CT Scan - 2020
Aclaris - ATI-450 - 2020
Pfizer - PF-06410293 - 2020
Lilly - LY3462817 - 2020
GlaxoSmithKline - GSK3196165 - 2021
UCB - Electrocemiluminescrent Immunoassay - 2021
Dr. Reddy - DRL_RI - 2021
Vorso - Vorso Project System (Nerve Stimulator) - 2021
Bristol Myers Squibb - Abatacept - 2022
Bristol Myers Squibb - Abatacept vs. Adalimumab - 2022
Bristol Myers Squibb - Branebrutinib - 2022
Lilly - LY3472817 - 2022
AbbVie - ABBV-154 - 2022
sarcopenia
Regeneron - REGN1033 - 2014
scleroderma/sclerosis
Actelion - Questionnaire - 2007
Actelion - Macitentan - 2011
MedImmune - MEDI 551 - 2011
skin or skin structure infection
TAP - Cefditoren - 1998
sjogren’s syndrome
Veldona - Interferon A - 1998
Snow Brand - Evoxac - 1997
Snow Brand - Evoxac - 1997
Veldona - Interferon A - 1999
Alcon - Rimexolone - 2003
TorreyPines - NGX267 - 2008
Parion - 552-02 - 2008
Novartis - CFZ533 - 2016
F. Hoffman/La Roche - RO5459072 - 2016
Bristol Myers Squibb - BMS-986142 - 2017
Bristol Myers Squibb - Abatacept - 2017
Lilly - LY3090106 - 2018
Gilead - Filgotinib - 2018
Primus - Survey - 2020
VielaBio - VIB4920 - 2022
Servier - S95011 - 2022
smokers
Philip Morris - No Drug - 2002
Philip Morris - Nicotine - 2004
Ulcerative colitis
Pharmacia - Celecoxib - 2001
Otsuka - OPC-6535 & Asacol - 2004
Cosmo - Asacol - 2008
Vaccine
Verve - Shingles - 2019
questionnaier for venous ulcer
Clintrials - No drug - 2002